Fusion Antibodies plc (AIM:FAB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11.56
-0.45 (-3.71%)
Sep 25, 2026, 4:10 PM GMT

Fusion Antibodies Ratios and Metrics

Millions GBP. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1516641016
Market Cap Growth
-29.52%142.24%80.40%-64.29%-35.83%-61.18%
Enterprise Value
141663914
Last Close Price
0.120.130.060.040.390.60

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
7.127.413.283.153.453.25
PB Ratio
9.269.648.532.008.924.24
P/TBV Ratio
9.269.648.532.008.924.24

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
6.787.473.082.763.152.87

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.200.200.030.020.070.02
Net Debt / Equity Ratio
-0.44-0.44-0.45-0.64-0.11-0.54
Net Debt / EBITDA Ratio
0.670.670.230.560.053.06
Net Debt / FCF Ratio
0.610.610.250.650.063.37
Asset Turnover
1.021.021.030.510.830.89
Inventory Turnover
2.792.794.212.364.144.38
Quick Ratio
2.082.081.362.891.012.54
Current Ratio
2.822.822.163.871.923.55
Return on Equity (ROE)
-96.64%-96.64%-127.58%-152.68%-108.01%-28.47%
Return on Assets (ROA)
-33.52%-33.52%-51.40%-63.36%-51.85%-15.41%
Return on Invested Capital (ROIC)
-121.87%-167.14%-298.86%-277.07%-213.82%-66.33%
Return on Capital Employed (ROCE)
-58.90%-58.90%-200.10%-123.70%-244.60%-35.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-7.65%-7.35%-25.20%-62.24%-25.92%-7.69%
FCF Yield
-7.81%-7.51%-21.30%-49.52%-18.65%-3.77%
Buyback Yield / Dilution
-20.26%-20.26%-72.58%-113.55%-0.27%-1.91%